Skip to main content
Article
Real world outcomes and management strategies for venetoclax-treated chronic lymphocytic leukemia patients in the United States.
Haematologica (2018)
  • Anthony R. Mato, Memorial Sloan Kettering Cancer Center
  • Meghan Thompson, University of Pennsylvania
  • John N. Allan, Cornell University
  • Danielle M. Brander, Duke University
  • John M. Pagel, Cancer Institute
  • Chaitra S. Ujjani, Georgetown University
  • Brian T. Hill, Cleveland Clinic
  • Nicole Lamanna, Columbia University
  • Frederick Lansigan, Dartmouth–Hitchcock Medical Center
  • Ryan Jacobs, Carolinas Healthcare System
  • Mazyar Shadman, Fred Hutchinson Cancer Research Center
  • Alan P. Skarbnik, Fox Chase Cancer Center
  • Jeffrey J. Pu, Pennsylvania State University
  • Paul M. Barr, University of Rochester
  • Alison R. Sehgal, University of Pittsburgh
  • Bruce D. Cheson, Georgetown University
  • Clive S. Zent, University of Rochester Medical Center
  • Hande H. Tuncer, Tufts University
  • Stephen J. Schuster, University of Pennsylvania
  • Peter V. Pickens, Abington Memorial Hospital
  • Nirav N. Shah, Medical College of Wisconsin
  • Andre Goy, Hackensack University Medical Center
  • Allison M. Winter, Cleveland Clinic
  • Christine Garcia, University of Pittsburgh
  • Kaitlin Kennard, University of Pennsylvania
  • Krista Isaac, Lankenau Medical Center
  • Colleen Dorsey, University of Pennsylvania
  • Lisa M. Gashonia, University of Pennsylvania
  • Arun K. Singavi, Medical College of Wisconsin
  • Lindsey E. Roeker, Memorial Sloan Kettering Cancer Center
  • Andrew Zelenetz, Memorial Sloan Kettering Cancer Center
  • Annalynn Williams, University of Rochester Medical Center
  • Christina Howlett, Hackensack University Medical Center
  • Hanna Weissbrot, Columbia University
  • Naveed Ali, Abington Memorial Hospital
  • Sirin Khajavian, Fred Hutchinson Cancer Research Center
  • Andrea Sitlinger, Duke University
  • Eve Tranchito, Cleveland Clinic
  • Joanna Rhodes, University of Pennsylvania
  • Joshua Felsenfeld, Cornell University
  • Neil Bailey, Cancer Institute
  • Bhavisha Patel, MedStar Washington Hospital Center
  • Timothy F. Burns, Dartmouth–Hitchcock Medical Center
  • Melissa Yacur, Pennsylvania State University
  • Mansi Malhotra, Tufts University
  • Jakub Svoboda, University of Pennsylvania
  • Richard R. Furman, Cornell University
  • Chadi Nabhan, University of Chicago
Publication Date
June 7, 2018
DOI
10.3324/haematol.2018.193615
Citation Information
Anthony R. Mato, Meghan Thompson, John N. Allan, Danielle M. Brander, et al.. "Real world outcomes and management strategies for venetoclax-treated chronic lymphocytic leukemia patients in the United States." Haematologica (2018)
Available at: http://works.bepress.com/john-pagel/2/